Cargando…
PMON70 Systemic Delivery of Leuprolide via Oral Administration
We have developed a technology platform employing enteric coating and permeation enhancement to enable systemic delivery of peptides via the oral route. To determine whether this platform can deliver therapeutic doses of the GnRH agonist leuprolide, we conducted a randomized, four-period, four-treat...
Autores principales: | Shangold, Gary, Rubin, Arkady, Daggs, Thomas, Vrettos, John, Rasums, Andrejs, Consalvo, Angelo, Skeet, Nicola, Shields, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625485/ http://dx.doi.org/10.1210/jendso/bvac150.1166 |
Ejemplares similares
-
PMON69 Effective Suppression of Gonadotropins and Gonadal Steroids Following Oral Administration of Leuprolide
por: Shangold, Gary, et al.
Publicado: (2022) -
SUN-421 Leuprolide Injection Induced Pituitary Apoplexy
por: Jaggi, Shirin, et al.
Publicado: (2019) -
PMON75 Unilateral Galactorrhea in an Elderly Male
por: Monsour, Elio, et al.
Publicado: (2022) -
PMON112 Primary Pituitary Lymphoma Presenting as Apoplexy
por: Abdelaziz, Sara, et al.
Publicado: (2022) -
PMON117 IGF-1 Testing: Diagnostic Pitfalls
por: Perez-Martinez, Sebastian
Publicado: (2022)